13 Sodium Dysregulation



M. Kamran Athar and Christian Bacheler


Abstract


Disorders of sodium regulation leading to either hyponatremia or hypernatremia are seen frequently in the critical care setting, and have particular importance in the setting of neurologic injury, surgery, and disease. This chapter is split into two major sections: hyponatremia and hypernatremia. For each, a basic overview with important features are provided, followed by a list of possible causes, an approach to the diagnosis (with specific focus on neurologically relevant etiologies such as syndrome of inappropriate antidiuretic hormone secretion (SIADH), cerebral salt wasting (CSW), and diabetes insipidus), and finally our recommendations on the general approach to treatment. Useful terminology and equations are also provided throughout the chapter that may assist in the bedside management while rounding in the critical care unit.




13 Sodium Dysregulation




13.1 Terminology




  • Tonicity: total concentration of nonpenetrating solutes (effective plasma osmolality)



  • Osmolarity: total concentration of penetrating and nonpenetrating solutes (mOsm/L of solution = mmol/L)



  • Osmolality: per kg of solvent (normal range: 275–290 mOsm/kg)



  • Calculation: Serum Osmolality = 2 × Serum [Na] + Serum Glucose/18 + Blood urea nitrogen (BUN)/2.8



13.2 Hyponatremia Classification


Multiple factors are taken into consideration when classifying hyponatremia. In addition to serum sodium concentration, the patient’s volume status and serum and urine osmolality should be taken into consideration. Hyponatremia is defined as serum [Na+] <135 mEq/L 1 with severity based on the concentration. Hyponatremia can be found in a wide range of hospitalized patients (1–15%) but is far more common in patients with neurologic injury ranging from 15 to 30% depending on the etiology. 23 Depending on the concentration, hyponatremia can be categorized by severity: Mild: 130–135 mEq/L, Moderate: 125–129 mEq/L; Severe: <125 mEq/L. It can be broken into additional categories based on serum osmolality and urine Na+ concentration (Fig. 13‑1).

Fig. 13.1 Diagnostic approach to hyponatremia.



13.2.1 Causes of Hyponatremia


There are multiple medical conditions associated with hyponatremia including surgery, critical illness, medications, and advanced age. Hyponatremia has also been associated in patients with traumatic brain injury, subarachnoid hemorrhage, meningitis, and brain tumors. Table 13‑1 details various causes of hyponatremia.


























































Table 13.1 Causes of hyponatremia based on classification

Causes of hyponatremia based on osmolality and volume status


Hypo-osmolar


euvolemia


Hypo-osmolar


hypervolemia


Hypo-osmolar


hypovolemia


Normo-osmolar


“pseudohyponatremia”


Hyper-osmolar


SIADH


Congestive heart failure


Renal Na+ losses


Extrarenal losses


Severe hypertriglyceridemia


Hyperglycemia


Hypothyroid


Acute or chronic renal failure


Diuretic use


Vomiting


Hyperproteinemia


Hypertonic infusions


Hypertonic saline


PAIN


Nephrotic syndrome


Cerebral salt wasting


Diarrhea


Mannitol infusion



Thiazide diuretics


Cirrhosis


Adrenal insufficiency


Excessive sweating


Ethanol ingestion



Water intoxication


Pregnancy


Renal tubular acidosis


“Third space” losses


Isotonic fluids




  • Glucose



  • Glycerol



  • Sorbitol



  • Glycine



Abbreviation: SIADH, syndrome of inappropriate antidiuretic hormone secretion.




13.2.2 Symptomatic Hyponatremia


Symptomatic hyponatremia typically occurs with a serum sodium concentration <125 mEq/L. However, symptoms are more likely to occur when there is a rapid sodium change. 2 In chronic conditions where the sodium concentration decreases over months, the brain is able to adapt by decreasing tonicity and subsequently the patient may remain relatively asymptomatic despite moderate to severe degree of hyponatremia. 3




  • Mild hyponatremia ([Na] 130–135 mEq/L): Asymptomatic



  • Moderate hyponatremia ([Na] 124–129 mEq/L): Nausea, malaise, confusion, headache, vomiting, lethargy, and increasing disorientation as the sodium concentration drops 3 , 22



  • Severe hyponatremia (typically [Na] <125 mEq/L): In addition to the abovementioned, seizures, coma, permanent brain damage, respiratory failure, brain stem herniation, and death 3 , 22


Seizures typically occur with serum sodium concentrations <120 mEq/L. Although the absolute risk of seizure ranges from 2.5 to 10% depending on the serum concentration with the higher risk related to concentrations <110 mEq/L. 4



13.3 SIADH versus CSW



13.3.1 Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)




  • Characterized by excessive antidiuretic hormone (ADH) release leading to increased renal water reabsorption, extracellular fluid (ECF) expansion, and hyponatremia. Due to a variety of causes (Table 13‑2), ADH is unable to be fully suppressed despite the condition of hypo-osmolality. 5



  • SIADH should be suspected in any patient with hyponatremia, hypo-osmolality, and a urine osmolality >100 mOsm/kg, after the exclusion of thyroid, adrenal, and renal causes. In SIADH, the urine sodium concentration is usually above 40 mEq/L, the serum potassium concentration is normal, there is no acid-base disturbance, and the serum uric acid concentration is frequently low. 6


























































Table 13.2 Causes of SIADH 2 , 3 , 6 , 7

Malignancy


Neurologic/Neuropsychiatric


Drugs/Medications


Other medical causes


Pulmonary tumors


Encephalitis/Meningitis


AVP analogues




  • DDAVP



  • Oxytocin



  • Vasopressin


Infection


Renal Cell Ca


Subarachnoid hemorrhage


Antiseizure meds




  • Carbamazepine



  • Valproate


Acute respiratory failure


Mediastinal tumors


Traumatic brain injury


Chemotherapeutics




  • Vincristine



  • Vinblastine



  • Cisplatin


Cystic fibrosis


Lymphoma/Leukemia


Intracerebral hemorrhage


SSRI, TCAs, MAOIs


HIV


Pituitary tumors


Stroke


Antipsychotics




  • Haldol



  • Thiothixene



  • Thioridazine



Nausea


Prostate


Demyelinating/Neuroinflammatory disorders


Amiodarone


Acute psychosis


Prolactinoma


Hydrocephalus


Amitriptyline


Stress


Osteosarcoma


Acute intermittent porphyria


MDMA “ecstasy”


Hereditary


Abbreviations: AVP, arginine vasopressin; DDAVP, 1-deamino-8-D-arginine-vasopressin; HIV, human immunodeficiency virus; MAOIs, monoamine oxidase inhibitors; MDMA, 3,4-methylenedioxymethamphetamine; SIADH, syndrome of inappropriate antidiuretic hormone secretion; SSRI, selective serotonin reuptake inhibitor; TCAs, tricyclic antidepressants.



13.3.2 Cerebral Salt Wasting (CSW)




  • Hypovolemic hyponatremia observed in subarachnoid hemorrhage, head injury, neurosurgical procedures, stroke, meningitis, and neoplasms (primitive neuroectodermal tumors with intraventricular dissemination, carcinomatous meningitis, glioma, and primary CNS lymphoma). 5 , 8



  • Hyponatremia is commonly seen in stroke, and may be from either SIADH or CSW. In ischemic stroke, hyponatremia has been reported in up to 11.5% of ischemic strokes, and 15.6% of intracerebral hemorrhage (ICH). 9 , 10 One study revealed hyponatremia to be present in 36.4% of ischemic strokes and 51.9% of ICH (over the entire hospital stay), and was attributed to CSW in 44.2% of cases. 11


It is characterized by volume contraction from renal salt wasting (differentiated from the volume expanded state of SIADH). It is important to distinguish CSW from SIADH.



13.3.3 SIADH and CSW Diagnosis


Accurate determination of the patient’s volume status is crucial to differentiate these syndromes (see Table 13‑3 and Fig. 13‑1). Physical examination and other clinical measures can be useful to assess volume status, with evidence of a hypovolemic state increasing the likelihood of a CSW diagnosis.




























































Table 13.3 Differentiating SIADH from CSW

Feature


SIADH


Cerebral salt wasting


Volume status


Euvolemia to mild hypervolemia


Hypovolemia


Serum [Na+]


Low


Low


Urine [Na+]


Increased (>40 mEq/L)


Increased (>40 mEq/L)


Serum osmolality


Low


Low


Urine osmolality


High (>100 mOsm/kg)


High (>100 mOsm/kg)


Urine output


Normal


Increased


Serum uric acid


Low


Normal or low


Serum bicarbonate


Normal or low


Increased


Central venous pressure


Normal or slightly elevated (6–10 cm H2O)


Low (<6 cm H2O)


BUN


Normal or low


Increased


Mechanism


Water retention due to increased ADH secretion


Excess secretion of water and sodium


Abbreviations: ADH, antidiuretic hormone; BUN, blood urea nitrogen; CSW, cerebral salt wasting; SIADH, syndrome of inappropriate antidiuretic hormone secretion.




13.4 Diagnostic Approach to Hyponatremia




  • Initial testing considerations: Basic metabolic panel, hepatic function panel, serum osmolality, urine sodium, urine osmolality, and thyroid stimulating hormone (TSH)



  • May also consider obtaining AM cortisol if adrenal insufficiency is suspected


Additional notes on serum osmolality:




  • Correction for hyperglycemia: To calculate the “corrected” serum sodium, we recommend the use of the following ratio: The sodium concentration will fall by 1.7 mEq/L for each 100 mg/100 mL (5.5 mmol/L) increase in glucose concentration. 12



  • Correct for azotemia: Tonicity = Measured serum osmolality – (BUN ÷ 2.8)


Dividing the BUN by 2.8 converts mg/dL of urea nitrogen into mmol/L of urea, which is required when calculating osmolality. If blood urea is measured in units of mmol/L, simply subtract without dividing by 2.8. 13



13.4.1 Hyponatremia Treatment: General Principles




  • Risk of osmotic demyelination (formerly known as central pontine myelinolysis)




    • High risk: [Na] <105 mEq/L, hypokalemia, alcoholism, malnutrition, and liver disease 14



    • Low risk: Hyperacute hyponatremia (over a few hours) as they have not had time to develop brain adaptations that increase risk of osmotic demyelination



  • Goal: Increase [Na+] by 6–8 mEq/L in 24 hours; 12–14 mEq/L in 48 hours.



  • Do not correct serum Na at a rate greater than 10 mEq/L in 24 hours (and no more than 18 in first 48 hours)



  • Recheck serum sodium every 4 hours for the first 24 hours, and at regular intervals thereafter until stabilized.



13.4.2 Acute Symptomatic Moderate to Severe Hyponatremia


Serum [Na] usually <129 mEq/L with symptoms that can include confusion, nausea (without vomiting), headache, somnolence, and hallucinations. More severe symptoms include: vomiting, seizures, cardiorespiratory arrest, abnormal and deep somnolence, and coma (Glasgow coma score [GCS] < 8).



Treatment

Use 3% hypertonic saline infusion to raise the serum [Na]




  • Initial emergent therapy: Over the first 4 to 6 hours, determine the rate to increase the serum [Na] by roughly 1 mEq/hour. It has been shown that a 4 to 6 mEq/L increase in Na concentration is adequate in the most seriously ill patients. 15


Note: With more severe symptoms, a 100 mL bolus of 3% hypertonic saline can be considered.




  • Check serum [Na] after 4 hours, and adjust rate of 3% hypertonic saline solution so that total rise in serum [Na] will not be greater than 10 to 12 mEq over the first 24-hour period.



Determining the Rate of 3% Hypertonic Saline Infusion



  • Determine the desired change in serum [Na] (and thus, the desired [Na])



  • Determine the desired timeframe to achieve this change



  • Determine rate of 3% hypertonic saline infusion using the following approach:


Solve for the amount of fluid needed to reach the desired [Na] by using this formula:


(Current amount of sodium in patient*) + (Sodium added with 3% saline)/(Total body water [TBW] + Amount of fluid added)  = Desired [Na](Current amount of sodium in patient*) + (Sodium added with 3% saline)/(Total body water [TBW] + Amount of fluid added) = Desired [Na]

Next, solve for the rate by dividing the amount of fluid added by the desired timeframe


Note: To determine current amount of sodium in patient, multiply the TBW by the current [Na]. TBW in L = Weight (kg) × 0.6 (or 0.5 in females)



Example of a Rate Calculation

Patient=70 kg male, Current Serum [Na]=115 mEq/L, Desired Serum [Na] =120 mEq/L, Desired time=5 hoursPatient=70\ kg\ male,\ Current\ Serum\ [Na]=115\ mEq/L,\ Desired\ Serum\ [Na]\ =120\ mEq/L,\ Desired\ time=5\ hours

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 6, 2021 | Posted by in NEUROLOGY | Comments Off on 13 Sodium Dysregulation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access